The interaction between HCV and nuclear receptor-mediated pathways

Pharmacology and Therapeutics

Volumn 132, Issue 1, 2011, Pages 30-38

  Raglow, Zoe ^a,b   Thoma Perry, Carly ^b   Gilroy, Richard ^a,b   Wan, Yu Jui Yvonne ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

Author keywords

Autophagy; Hepatitis; Liver; Retinoic acid; Retinoic acid receptor; Steatosis

Indexed keywords

ALITRETINOIN; ANTIVIRUS AGENT; BEZAFIBRATE; CLOFIBRATE; FARNESOID X RECEPTOR; FENOFIBRATE; LIVER X RECEPTOR; PEGINTERFERON; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; RETINOIC ACID; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR; RIBAVIRIN; ROSIGLITAZONE;

ANTIVIRAL ACTIVITY; ANTIVIRAL THERAPY; AUTOPHAGY; CELL PROLIFERATION; DRUG POTENTIATION; FATTY ACID METABOLISM; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERLIPIDEMIA; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER METABOLISM; LIVER TRANSPLANTATION; NEOPLASM; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; VIRUS CELL INTERACTION; VIRUS IMMUNITY; VIRUS ONCOGENE; VIRUS PATHOGENESIS;

ANIMALS; ANTIVIRAL AGENTS; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER; LIVER TRANSPLANTATION; MOLECULAR TARGETED THERAPY; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 79960596493     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2011.05.005     Document Type: Review

References (111)

1. M.Y. Abdalla, I.M. Ahmad, D.R. Spitz, W.N. Schmidt, and B.E. Britigan Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses J Med Virol 76 2005 489 497 (Pubitemid 40943258)
2. L.E. Adinolfi, M. Gambardella, A. Andreana, M.F. Tripodi, R. Utili, and G. Ruggiero Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity Hepatology 33 2001 1358 1364 (Pubitemid 32496971)
3. H. Barth, T.J. Liang, and T.F. Baumert Hepatitis C virus entry: Molecular biology and clinical implications Hepatology 44 2006 527 535 (Pubitemid 44433708)
4. S.W. Beaven, K. Wroblewski, J. Wang, C. Hong, S. Bensinger, and H. Tsukamoto Liver X receptor signaling is a determinant of stellate cell activation and susceptibility to fibrotic liver disease Gastroenterology 2010
5. K.D. Bissig, S.F. Wieland, P. Tran, M. Isogawa, T.T. Le, and F.V. Chisari Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment J Clin Invest 120 2010 924 930
6. S. Blackham, A. Baillie, F. Al-Hababi, K. Remlinger, S. You, and R. Hamatake Gene expression profiling indicates the roles of host oxidative stress, apoptosis, lipid metabolism, and intracellular transport genes in the replication of hepatitis C virus J Virol 84 2010 5404 5414
7. W.O. Bocher, C. Wallasch, T. Hohler, and P.R. Galle All-trans retinoic acid for treatment of chronic hepatitis C Liver Int 28 2008 347 354 (Pubitemid 351279582)
8. S. Boulant, M.W. Douglas, L. Moody, A. Budkowska, P. Targett-Adams, and J. McLauchlan Hepatitis C virus core protein induces lipid droplet redistribution in a microtubule- and dynein-dependent manner Traffic 9 2008 1268 1282 (Pubitemid 352016286)
9. V. Brass, D. Moradpour, and H.E. Blum Hepatitis C virus infection: In vivo and in vitro models J Viral Hepat 14 Suppl 1 2007 64 67 (Pubitemid 47624115)
10. R. Bruck, S. Weiss, H. Aeed, M. Pines, Z. Halpern, and I. Zvibel Additive inhibitory effect of experimentally induced hepatic cirrhosis by agonists of peroxisome proliferator activator receptor gamma and retinoic acid receptor Dig Dis Sci 54 2009 292 299
11. K.P. Burke, and A.L. Cox Hepatitis C virus evasion of adaptive immune responses: A model for viral persistence Immunol Res 47 2010 216 227
12. N. Bushue, and Y.J. Wan Retinoid Pathway and Cancer Therapeutics Advanced drug delivery 2010
13. P. Chambon A decade of molecular biology of retinoic acid receptors FASEB J 10 1996 940 954 (Pubitemid 26285969)
14. K.O. Chang, and D.W. George Bile acids promote the expression of hepatitis C virus in replicon-harboring cells J Virol 81 2007 9633 9640 (Pubitemid 350067669)
15. K.O. Chang, S.V. Sosnovtsev, G. Belliot, Y. Kim, L.J. Saif, and K.Y. Green Bile acids are essential for porcine enteric calicivirus replication in association with down-regulation of signal transducer and activator of transcription 1 Proc Natl Acad Sci USA 101 2004 8733 8738 (Pubitemid 38745840)
16. K. Chayama, C.N. Hayes, N. Hiraga, H. Abe, M. Tsuge, and M. Imamura Animal model for study of human hepatitis viruses J Gastroenterol Hepatol 26 2011 13 18
17. Y. Cheng, S. Dharancy, M. Malapel, and P. Desreumaux Hepatitis C virus infection down-regulates the expression of peroxisome proliferator-activated receptor alpha and carnitine palmitoyl acyl-CoA transferase 1A World J Gastroenterol 11 2005 7591 7596 (Pubitemid 43168421)
18. P.R. Devchand, H. Keller, J.M. Peters, M. Vazquez, F.J. Gonzalez, and W. Wahli The PPARalpha-leukotriene B4 pathway to inflammation control Nature 384 1996 39 43
19. S. Dharancy, M. Malapel, G. Perlemuter, T. Roskams, Y. Cheng, and L. Dubuquoy Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection Gastroenterology 128 2005 334 342 (Pubitemid 40431087)
20. M.W. Douglas, and J. George Molecular mechanisms of insulin resistance in chronic hepatitis C World J Gastroenterol 15 2009 4356 4364
21. M. Dreux, P. Gastaminza, S.F. Wieland, and F.V. Chisari The autophagy machinery is required to initiate hepatitis C virus replication Proc Natl Acad Sci USA 106 2009 14046 14051
22. J. Dubuisson, F. Helle, and L. Cocquerel Early steps of the hepatitis C virus life cycle Cell Microbiol 10 2008 821 827 (Pubitemid 351386938)
23. M.J. Evans, T. von Hahn, D.M. Tscherne, A.J. Syder, M. Panis, and B. Wolk Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry Nature 446 2007 801 805 (Pubitemid 46582027)
24. J.J. Feld, and T.J. Liang Hepatitis C-identifying patients with progressive liver injury Hepatology 43 2006 S194 S206
25. S. Fiorucci, E. Antonelli, G. Rizzo, B. Renga, A. Mencarelli, and L. Riccardi The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis Gastroenterology 127 2004 1497 1512 (Pubitemid 39457775)
26. S. Fiorucci, G. Rizzo, E. Antonelli, B. Renga, A. Mencarelli, and L. Riccardi A farnesoid x receptor-small heterodimer partner regulatory cascade modulates tissue metalloproteinase inhibitor-1 and matrix metalloprotease expression in hepatic stellate cells and promotes resolution of liver fibrosis J Pharmacol Exp Ther 314 2005 584 595 (Pubitemid 41043838)
27. A.J. Fowell, and K.L. Nash Telaprevir: A new hope in the treatment of chronic hepatitis C? Adv Ther 27 2010 512 522
28. N. Fujita, M. Kaito, M. Kai, R. Sugimoto, H. Tanaka, and S. Horiike Effects of bezafibrate in patients with chronic hepatitis C virus infection: Combination with interferon and ribavirin J Viral Hepat 13 2006 441 448
29. N. Fujita, M. Kaito, H. Tanaka, S. Horiike, and Y. Adachi Reduction of serum HCV RNA titer by bezafibrate therapy in patients with chronic hepatitis C Am J Gastroenterol 99 2004 2280 (Pubitemid 39524721)
30. R.M. Gadaleta, S.W. van Mil, B. Oldenburg, P.D. Siersema, L.W. Klomp, and K.J. van Erpecum Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease Biochim Biophys Acta 1801 2010 683 692
31. M. Gale Jr., and E.M. Foy Evasion of intracellular host defence by hepatitis C virus Nature 436 2005 939 945 (Pubitemid 41191669)
32. P. Gastaminza, G. Cheng, S. Wieland, J. Zhong, W. Liao, and F.V. Chisari Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion J Virol 82 2008 2120 2129 (Pubitemid 351293514)
33. O. Gavrilova, M. Haluzik, K. Matsusue, J.J. Cutson, L. Johnson, and K.R. Dietz Liver peroxisome proliferator-activated receptor gamma contributes to hepatic steatosis, triglyceride clearance, and regulation of body fat mass J Biol Chem 278 2003 34268 34276 (Pubitemid 37553270)
34. P. Gervois, R. Kleemann, A. Pilon, F. Percevault, W. Koenig, and B. Staels Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate J Biol Chem 279 2004 16154 16160 (Pubitemid 38509307)
35. C.K. Glass, and K. Saijo Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells Nat Rev Immunol 10 2010 365 376
36. F.J. Gonzalez, and Y.M. Shah PPARalpha: Mechanism of species differences and hepatocarcinogenesis of peroxisome proliferators Toxicology 246 2008 2 8
37. C. Guevin, D. Manna, C. Belanger, K.V. Konan, P. Mak, and P. Labonte Autophagy protein ATG5 interacts transiently with the hepatitis C virus RNA polymerase (NS5B) early during infection Virology 405 2010 1 7
38. M.A. Gyamfi, and Y.J. Wan Pathogenesis of alcoholic liver disease: The role of nuclear receptors Exp Biol Med (Maywood) 235 2010 547 560
39. S. Hamamoto, R. Fukuda, N. Ishimura, M.A. Rumi, H. Kazumori, and Y. Uchida 9-cis retinoic acid enhances the antiviral effect of interferon on hepatitis C virus replication through increased expression of type I interferon receptor J Lab Clin Med 141 2003 58 66 (Pubitemid 36065087)
40. C. Hong, S. Duit, P. Jalonen, R. Out, L. Scheer, and V. Sorrentino The E3 ubiquitin ligase IDOL induces the degradation of the low density lipoprotein receptor family members VLDLR and ApoER2 J Biol Chem 285 2010 19720 19726
41. E. Ip, G. Farrell, P. Hall, G. Robertson, and I. Leclercq Administration of the potent PPARalpha agonist, Wy-14,643, reverses nutritional fibrosis and steatohepatitis in mice Hepatology 39 2004 1286 1296 (Pubitemid 38569050)
42. M. Jiang, S. Fernandez, W.G. Jerome, Y. He, X. Yu, and H. Cai Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy Cell Death Differ 17 2010 469 481
43. M.A. Joyce, and D.L. Tyrrell The cell biology of hepatitis C virus Microbes Infect 12 2010 263 271
44. S.B. Kapadia, and F.V. Chisari Hepatitis C virus RNA replication is regulated by host geranylgeranylation and fatty acids Proc Natl Acad Sci USA 102 2005 2561 2566 (Pubitemid 40279416)
45. M. Khattab, M. Emad, A. Abdelaleem, M. Eslam, R. Atef, and Y. Shaker Pioglitazone improves virological response to peginterferon alpha-2b/ribavirin combination therapy in hepatitis C genotype 4 patients with insulin resistance Liver Int 30 2010 447 454
46. K.H. Kim, S.P. Hong, K. Kim, M.J. Park, K.J. Kim, and J. Cheong HCV core protein induces hepatic lipid accumulation by activating SREBP1 and PPARgamma Biochem Biophys Res Commun 355 2007 883 888 (Pubitemid 46366910)
47. K. Kim, K.H. Kim, E. Ha, J.Y. Park, N. Sakamoto, and J. Cheong Hepatitis C virus NS5A protein increases hepatic lipid accumulation via induction of activation and expression of PPARgamma FEBS Lett 583 2009 2720 2726
48. R. Kleemann, P.P. Gervois, L. Verschuren, B. Staels, H.M. Princen, and T. Kooistra Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation Blood 101 2003 545 551 (Pubitemid 36077576)
49. K. Koike Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection J Gastroenterol 44 Suppl 19 2009 82 88
50. Y.S. Lee, D. Chanda, J. Sim, Y.Y. Park, and H.S. Choi Structure and function of the atypical orphan nuclear receptor small heterodimer partner Int Rev Cytol 261 2007 117 158 (Pubitemid 46856618)
51. Z.H. Li, Q.B. Tang, J. Wang, L. Zhou, W.L. Huang, and R.Y. Liu Hepatitis C virus core protein induces malignant transformation of biliary epithelial cells by activating nuclear factor-kappaB pathway J Gastroenterol Hepatol 25 2010 1315 1320
52. E. Lima-Cabello, M.V. Garcia-Mediavilla, M.E. Miquilena-Colina, J. Vargas-Castrillon, T. Lozano-Rodriguez, and M. Fernandez-Bermejo Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C Clin Sci (Lond) 120 2010 239 250
53. R.K. Lyn, D.C. Kennedy, S.M. Sagan, D.R. Blais, Y. Rouleau, and A.F. Pegoraro Direct imaging of the disruption of hepatitis C virus replication complexes by inhibitors of lipid metabolism Virology 394 2009 130 142
54. P. Maison, L. Mennen, D. Sapinho, B. Balkau, J. Sigalas, and M.C. Chesnier A pharmacoepidemiological assessment of the effect of statins and fibrates on fibrinogen concentration Atherosclerosis 160 2002 155 160 (Pubitemid 34076650)
55. F. Marra, E. Efsen, R.G. Romanelli, A. Caligiuri, S. Pastacaldi, and G. Batignani Ligands of peroxisome proliferator-activated receptor gamma modulate profibrogenic and proinflammatory actions in hepatic stellate cells Gastroenterology 119 2000 466 478 (Pubitemid 30621997)
56. N. Marx, G.K. Sukhova, T. Collins, P. Libby, and J. Plutzky PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells Circulation 99 1999 3125 3131 (Pubitemid 29289077)
57. N.J. McKenna, A.J. Cooney, F.J. DeMayo, M. Downes, C.K. Glass, and R.B. Lanz Minireview: Evolution of NURSA, the Nuclear Receptor Signaling Atlas Mol Endocrinol 23 2009 740 746
58. D.F. Mercer, D.E. Schiller, J.F. Elliott, D.N. Douglas, C. Hao, and A. Rinfret Hepatitis C virus replication in mice with chimeric human livers Nat Med 7 2001 927 933 (Pubitemid 32756430)
59. Y. Miyanari, K. Atsuzawa, N. Usuda, K. Watashi, T. Hishiki, and M. Zayas The lipid droplet is an important organelle for hepatitis C virus production Nat Cell Biol 9 2007 1089 1097 (Pubitemid 47338147)
60. M. Morbitzer, and T. Herget Expression of gastrointestinal glutathione peroxidase is inversely correlated to the presence of hepatitis C virus subgenomic RNA in human liver cells J Biol Chem 280 2005 8831 8841 (Pubitemid 40409572)
61. K. Moriishi, R. Mochizuki, K. Moriya, H. Miyamoto, Y. Mori, and T. Abe Critical role of PA28gamma in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis Proc Natl Acad Sci USA 104 2007 1661 1666 (Pubitemid 46214647)
62. K. Motojima, P. Passilly, J.M. Peters, F.J. Gonzalez, and N. Latruffe Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner J Biol Chem 273 1998 16710 16714 (Pubitemid 28311694)
63. M.H. Nguyen, and E.B. Keeffe Chronic hepatitis C: Genotypes 4 to 9 Clin Liver Dis 9 2005 411 426 vi (Pubitemid 40968204)
64. NIH Consensus Statement on Management of Hepatitis C: 2002 NIH Consens State Sci Statements 19 2002 1 46
65. Y. Nishimura-Sakurai, N. Sakamoto, K. Mogushi, S. Nagaie, M. Nakagawa, and Y. Itsui Comparison of HCV-associated gene expression and cell signaling pathways in cells with or without HCV replicon and in replicon-cured cells J Gastroenterol 45 2010 523 536
66. M. Okuda, K. Li, M.R. Beard, L.A. Showalter, F. Scholle, and S.M. Lemon Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein Gastroenterology 122 2002 366 375 (Pubitemid 34116988)
67. K. Overbeck, D. Genne, A. Golay, and F. Negro Pioglitazone in chronic hepatitis C not responding to pegylated interferon-alpha and ribavirin J Hepatol 49 2008 295 298
68. C. Pasquinelli, J.M. Shoenberger, J. Chung, K.M. Chang, L.G. Guidotti, and M. Selby Hepatitis C virus core and E2 protein expression in transgenic mice Hepatology 25 1997 719 727 (Pubitemid 27106460)
69. J.M. Pawlotsky, S. Chevaliez, and J.G. McHutchison The hepatitis C virus life cycle as a target for new antiviral therapies Gastroenterology 132 2007 1979 1998 (Pubitemid 46695724)
70. V. Pazienza, S. Clement, P. Pugnale, S. Conzelman, M. Foti, and A. Mangia The hepatitis C virus core protein of genotypes 3a and 1b downregulates insulin receptor substrate 1 through genotype-specific mechanisms Hepatology 45 2007 1164 1171 (Pubitemid 46775778)
71. V. Pazienza, M. Vinciguerra, A. Andriulli, and A. Mangia Hepatitis C virus core protein genotype 3a increases SOCS-7 expression through PPAR-{gamma} in Huh-7 cells J Gen Virol 91 2010 1678 1686
72. K.H. Pearce, M.A. Iannone, C.A. Simmons, and J.G. Gray Discovery of novel nuclear receptor modulating ligands: An integral role for peptide interaction profiling Drug Discov Today 9 2004 741 751 (Pubitemid 39140801)
73. J.M. Petit, A. Minello, V. Jooste, J.B. Bour, F. Galland, and L. Duvillard Decreased plasma adiponectin concentrations are closely related to steatosis in hepatitis C virus-infected patients J Clin Endocrinol Metab 90 2005 2240 2243 (Pubitemid 40586268)
74. A. Ploss, M.J. Evans, V.A. Gaysinskaya, M. Panis, H. You, and Y.P. de Jong Human occludin is a hepatitis C virus entry factor required for infection of mouse cells Nature 457 2009 882 886
75. A. Ploss, and C.M. Rice Towards a small animal model for hepatitis C EMBO Rep 10 2009 1220 1227
76. H. Poirier, I. Niot, M.C. Monnot, O. Braissant, C. Meunier-Durmort, and P. Costet Differential involvement of peroxisome-proliferator-activated receptors alpha and delta in fibrate and fatty-acid-mediated inductions of the gene encoding liver fatty-acid-binding protein in the liver and the small intestine Biochem J 355 2001 481 488 (Pubitemid 32397809)
77. J.D. Rabinowitz, and E. White Autophagy and metabolism Science 330 2010 1344 1348
78. B. Rakic, S.M. Sagan, M. Noestheden, S. Belanger, X. Nan, and C.L. Evans Peroxisome proliferator-activated receptor alpha antagonism inhibits hepatitis C virus replication Chem Biol 13 2006 23 30 (Pubitemid 43099921)
79. J.K. Reddy Nonalcoholic steatosis and steatohepatitis. III. Peroxisomal beta-oxidation, PPAR alpha, and steatohepatitis Am J Physiol Gastrointest Liver Physiol 281 2001 G1333 G1339
80. C. Scholtes, O. Diaz, V. Icard, A. Kaul, R. Bartenschlager, and V. Lotteau Enhancement of genotype 1 hepatitis C virus replication by bile acids through FXR J Hepatol 48 2008 192 199
81. M.Y. Sheikh, J. Choi, I. Qadri, J.E. Friedman, and A.J. Sanyal Hepatitis C virus infection: Molecular pathways to metabolic syndrome Hepatology 47 2008 2127 2133 (Pubitemid 351945577)
82. S. Shrivastava, A. Raychoudhuri, R. Steele, R. Ray, and R.B. Ray Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes Hepatology 53 2011 406 414
83. R. Singh, S. Kaushik, Y. Wang, Y. Xiang, I. Novak, and M. Komatsu Autophagy regulates lipid metabolism Nature 458 2009 1131 1135
84. D. Sir, C. Liang, W.L. Chen, J.U. Jung, and J.H. Ou Perturbation of autophagic pathway by hepatitis C virus Autophagy 4 2008 830 831
85. N. Tanaka, K. Moriya, K. Kiyosawa, K. Koike, and T. Aoyama Hepatitis C virus core protein induces spontaneous and persistent activation of peroxisome proliferator-activated receptor alpha in transgenic mice: Implications for HCV-associated Hepatocarcinogenesis Int J Cancer 122 2008 124 131 (Pubitemid 350209986)
86. N. Tanaka, K. Moriya, K. Kiyosawa, K. Koike, F.J. Gonzalez, and T. Aoyama PPARalpha activation is essential for HCV core protein-induced hepatic steatosis and hepatocellular carcinoma in mice J Clin Invest 118 2008 683 694 (Pubitemid 351206557)
87. X.H. Tang, and L.J. Gudas Retinoids, retinoic acid receptors, and cancer Annu Rev Pathol 2010
88. H. Tang, and A. McLachlan Transcriptional regulation of hepatitis B virus by nuclear hormone receptors is a critical determinant of viral tropism Proc Natl Acad Sci USA 98 2001 1841 1846 (Pubitemid 32165585)
89. T. Toyama, H. Nakamura, Y. Harano, N. Yamauchi, A. Morita, and T. Kirishima PPARalpha ligands activate antioxidant enzymes and suppress hepatic fibrosis in rats Biochem Biophys Res Commun 324 2004 697 704 (Pubitemid 39345573)
90. T. Tsutsumi, T. Suzuki, T. Shimoike, R. Suzuki, K. Moriya, and Y. Shintani Interaction of hepatitis C virus core protein with retinoid X receptor alpha modulates its transcriptional activity Hepatology 35 2002 937 946 (Pubitemid 34258390)
91. P. Vavassori, A. Mencarelli, B. Renga, E. Distrutti, and S. Fiorucci The bile acid receptor FXR is a modulator of intestinal innate immunity J Immunol 183 2009 6251 6261
92. Y.J. Wan, D. An, Y. Cai, J.J. Repa, T. Hung-Po Chen, and M. Flores Hepatocyte-specific mutation establishes retinoid X receptor alpha as a heterodimeric integrator of multiple physiological processes in the liver Mol Cell Biol 20 2000 4436 4444 (Pubitemid 30346638)
93. K. Wang, I. Damjanov, and Y.J. Wan The protective role of pregnane X receptor in lipopolysaccharide/d-galactosamine-induced acute liver injury Lab Invest 90 2010 257 265
94. L. Wang, J.J. Potter, L. Rennie-Tankersley, G. Novitskiy, J. Sipes, and E. Mezey Effects of retinoic acid on the development of liver fibrosis produced by carbon tetrachloride in mice Biochim Biophys Acta 1772 2007 66 71 (Pubitemid 44960723)
95. L. Wang, L.R. Tankersley, M. Tang, J.J. Potter, and E. Mezey Regulation of the murine alpha(2)(I) collagen promoter by retinoic acid and retinoid X receptors Arch Biochem Biophys 401 2002 262 270 (Pubitemid 34848629)
96. K. Wang, and Y.J. Wan Nuclear receptors and inflammatory diseases Exp Biol Med (Maywood) 233 2008 496 506 (Pubitemid 351657351)
97. M.L. Washburn, M.T. Bility, L. Zhang, G.I. Kovalev, A. Buntzman, and J.A. Frelinger A humanized mouse model to study hepatitis C virus infection, immune response, and liver disease Gastroenterology 140 2011 1334 1344
98. K. Watashi, M. Hijikata, A. Tagawa, T. Doi, H. Marusawa, and K. Shimotohno Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus Mol Cell Biol 23 2003 7498 7509 (Pubitemid 37271451)
99. S.D. Woodhouse, R. Narayan, S. Latham, S. Lee, R. Antrobus, and B. Gangadharan Transcriptome sequencing, microarray, and proteomic analyses reveal cellular and metabolic impact of hepatitis C virus infection in vitro Hepatology 52 2010 443 453
100. T. Yamauchi, J. Kamon, H. Waki, Y. Terauchi, N. Kubota, and K. Hara The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity Nat Med 7 2001 941 946 (Pubitemid 32756432)
101. L. Yang, C.C. Chan, O.S. Kwon, S. Liu, J. McGhee, and S.A. Stimpson Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis Am J Physiol Gastrointest Liver Physiol 291 2006 G902 G911 (Pubitemid 44772017)
102. L. Yang, P. Li, S. Fu, E.S. Calay, and G.S. Hotamisligil Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance Cell Metab 11 2010 467 478
103. Q. Yang, T. Nagano, Y. Shah, C. Cheung, S. Ito, and F.J. Gonzalez The PPAR alpha-humanized mouse: A model to investigate species differences in liver toxicity mediated by PPAR alpha Toxicol Sci 101 2008 132 139 (Pubitemid 350239017)
104. K. Yasui, Y. Harano, H. Mitsuyoshi, K. Tsuji, M. Endo, and T. Nakajima Steatosis and hepatic expression of genes regulating lipid metabolism in Japanese patients infected with hepatitis C virus J Gastroenterol 45 2010 95 104
105. S. Yu, K. Matsusue, P. Kashireddy, W.Q. Cao, V. Yeldandi, and A.V. Yeldandi Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression J Biol Chem 278 2003 498 505 (Pubitemid 36043602)
106. J. Yu, S. Zhang, E.S. Chu, M.Y. Go, R.H. Lau, and J. Zhao Peroxisome proliferator-activated receptors gamma reverses hepatic nutritional fibrosis in mice and suppresses activation of hepatic stellate cells in vitro Int J Biochem Cell Biol 42 2010 948 957
107. S. Zhang, J. Wang, Q. Liu, and D.C. Harnish Farnesoid X receptor agonist WAY-362450 attenuates liver inflammation and fibrosis in murine model of non-alcoholic steatohepatitis J Hepatol 51 2009 380 388
108. C. Zhao, W. Chen, L. Yang, L. Chen, S.A. Stimpson, and A.M. Diehl PPARgamma agonists prevent TGFbeta1/Smad3-signaling in human hepatic stellate cells Biochem Biophys Res Commun 350 2006 385 391 (Pubitemid 44498647)
109. C. Zhao, and K. Dahlman-Wright Liver X receptor in cholesterol metabolism J Endocrinol 204 2010 233 240
110. J. Zhou, Y. Zhai, Y. Mu, H. Gong, H. Uppal, and D. Toma A novel pregnane X receptor-mediated and sterol regulatory element-binding protein-independent lipogenic pathway J Biol Chem 281 2006 15013 15020 (Pubitemid 43855205)
111. J. Zhou, W. Zhang, B. Liang, M.C. Casimiro, D. Whitaker-Menezes, and M. Wang PPARgamma activation induces autophagy in breast cancer cells Int J Biochem Cell Biol 41 2009 2334 2342